187 related articles for article (PubMed ID: 17694543)
1. Influence of intravesicular pH drift and membrane binding on the liposomal release of a model amine-containing permeant.
Tejwani RW; Anderson BD
J Pharm Sci; 2008 Jan; 97(1):381-99. PubMed ID: 17694543
[TBL] [Abstract][Full Text] [Related]
2. Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.
Joguparthi V; Anderson BD
J Pharm Sci; 2008 Jan; 97(1):433-54. PubMed ID: 17918731
[TBL] [Abstract][Full Text] [Related]
3. Liposome transport of hydrophobic drugs: gel phase lipid bilayer permeability and partitioning of the lactone form of a hydrophobic camptothecin, DB-67.
Joguparthi V; Xiang TX; Anderson BD
J Pharm Sci; 2008 Jan; 97(1):400-20. PubMed ID: 17879989
[TBL] [Abstract][Full Text] [Related]
4. Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions.
Modi S; Xiang TX; Anderson BD
J Control Release; 2012 Sep; 162(2):330-9. PubMed ID: 22800581
[TBL] [Abstract][Full Text] [Related]
5. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
[TBL] [Abstract][Full Text] [Related]
6. Determination of key parameters for a mechanism-based model to predict Doxorubicin release from actively loaded liposomes.
Csuhai E; Kangarlou S; Xiang TX; Ponta A; Bummer P; Choi D; Anderson BD
J Pharm Sci; 2015 Mar; 104(3):1087-98. PubMed ID: 25561354
[TBL] [Abstract][Full Text] [Related]
7. Transport methods for probing the barrier domain of lipid bilayer membranes.
Xiang TX; Chen X; Anderson BD
Biophys J; 1992 Jul; 63(1):78-88. PubMed ID: 1420875
[TBL] [Abstract][Full Text] [Related]
8. The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.
Fugit KD; Anderson BD
J Control Release; 2014 Jan; 174():88-97. PubMed ID: 24231406
[TBL] [Abstract][Full Text] [Related]
9. Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes.
Devarakonda B; Otto DP; Judefeind A; Hill RA; de Villiers MM
Int J Pharm; 2007 Dec; 345(1-2):142-53. PubMed ID: 17600643
[TBL] [Abstract][Full Text] [Related]
10. Determination of drug release kinetics from nanoparticles: overcoming pitfalls of the dynamic dialysis method.
Modi S; Anderson BD
Mol Pharm; 2013 Aug; 10(8):3076-89. PubMed ID: 23758289
[TBL] [Abstract][Full Text] [Related]
11. Comparing the lipid membrane affinity and permeation of drug-like acids: the intriguing effects of cholesterol and charged lipids.
Thomae AV; Koch T; Panse C; Wunderli-Allenspach H; Krämer SD
Pharm Res; 2007 Aug; 24(8):1457-72. PubMed ID: 17387599
[TBL] [Abstract][Full Text] [Related]
12. Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers.
He N; Warner KS; Higuchi WI; Li SK
Int J Pharm; 2005 Jun; 297(1-2):9-21. PubMed ID: 15907593
[TBL] [Abstract][Full Text] [Related]
13. Development of structure-lipid bilayer permeability relationships for peptide-like small organic molecules.
Cao Y; Xiang TX; Anderson BD
Mol Pharm; 2008; 5(3):371-88. PubMed ID: 18355031
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous domains and membrane permeability in phosphatidylcholine-phosphatidic acid rigid vesicles as a function of pH and lipid chain mismatch.
Karve S; Bajagur Kempegowda G; Sofou S
Langmuir; 2008 Jun; 24(11):5679-88. PubMed ID: 18471003
[TBL] [Abstract][Full Text] [Related]
15. Influence of chain ordering on the selectivity of dipalmitoylphosphatidylcholine bilayer membranes for permeant size and shape.
Xiang TX; Anderson BD
Biophys J; 1998 Dec; 75(6):2658-71. PubMed ID: 9826590
[TBL] [Abstract][Full Text] [Related]
16. Independence of substituent contributions to the transport of small molecule permeants in lipid bilayers.
Mayer PT; Xiang TX; Anderson BD
AAPS PharmSci; 2000; 2(2):E14. PubMed ID: 11741230
[TBL] [Abstract][Full Text] [Related]
17. Effect of fatty acids on the permeability barrier of model and biological membranes.
Arouri A; Lauritsen KE; Nielsen HL; Mouritsen OG
Chem Phys Lipids; 2016 Oct; 200():139-146. PubMed ID: 27725161
[TBL] [Abstract][Full Text] [Related]
18. Determination of intraliposomal pH and its effect on membrane partitioning and passive loading of a hydrophobic camptothecin, DB-67.
Joguparthi V; Feng S; Anderson BD
Int J Pharm; 2008 Mar; 352(1-2):17-28. PubMed ID: 18065174
[TBL] [Abstract][Full Text] [Related]
19. Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent.
Ali MH; Kirby DJ; Mohammed AR; Perrie Y
J Pharm Pharmacol; 2010 Nov; 62(11):1646-55. PubMed ID: 21039548
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Titratable Amphiphiles in Lipid Membranes by Fluorescence Spectroscopy.
Pierrat P; Lebeau L
Langmuir; 2015 Nov; 31(45):12362-71. PubMed ID: 26507074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
